A TRADE MEDIA PLATFORM

Out of the Lab

Out of the Lab

The video-first trade publication examining the CMC, analytical, and supply chain bottlenecks standing between scientific discovery and commercial patient delivery in Cell & Gene Therapy.

The video-first trade publication examining the CMC, analytical, and supply chain bottlenecks standing between scientific discovery and commercial patient delivery in Cell & Gene Therapy.

$15.7 Billion

Active Annual Audience Controlled Manufacturing & Pipeline Budget Oversight

74%

VP, Director & C-Suite Seniority Guests

Global Hubs

Distribution Across US, UK, EU, APAC Biomanufacturing Centers

CDMO

Minaris Viral Vectors

Minaris Viral Vectors

President

President

Minaris Viral Vectors President Eytan Abraham explores the unique manufacturing scalability and strategic CMC (Chemistry, Manufacturing, and Controls) challenges associated with transitioning from ex vivo personalized cell therapies to off-the-shelf in vivo viral vector therapies.

Minaris Viral Vectors President Eytan Abraham explores the unique manufacturing scalability and strategic CMC (Chemistry, Manufacturing, and Controls) challenges associated with transitioning from ex vivo personalized cell therapies to off-the-shelf in vivo viral vector therapies.

Complete Index

The companies we've featured


Accenture

Cell & Gene Consulting

Forge Biologics

Northern RNA

Advanced Therapies Think Tank

CellBri

Genedata

Ori Biotech

Akadeum Life Sciences

CellWise Consulting

Eldred Advisors

Orphan Therapeutics Accelerator

CCRM (Centre for Commercialization)

Children’s Hospital of Orange County

HINA Bio-ventures

PharmaFlow Limited

BAG Health Care

Cholangiocarcinoma Foundation

Kosten Digital

Pivot Bio

BioBridge Global

DeciBio

Minaris Advanced Therapies

SamOh Pharmaceuticals

Catalent Pharma Solutions

DISCO

National Institutes & FDA Panelists

ScaleReady





Sovereign Industry Placement.

We co-develop diagnostic miniseries and host multi-stakeholder panel syndications alongside the leaders moving advanced modalities forward.

© 2026 OUT OF THE LAB

ADVANCED MEDICINE. UNFILTERED.